Dr. Jacob Ezra Shabason, MD

Dr. Shabason practices at HCA HealthONE Sky Ridge in Lone Tree, Colorado, part of HCA Healthcare.

Dr. Shabason's NPI, 1700176534, was assigned on April 13, 2011. Dr. Shabason graduated from Perelman School of Med at the University of Pennsylvania in 2011. Dr. Shabason holds Colorado license DR.0070101.

Dr. Shabason's primary practice is HCA HealthONE Sky Ridge, at 10101 Ridgegate Pkwy, Lone Tree, CO 80124 in Douglas County. The practice phone is (720) 225-1000.

Dr. Shabason's primary practice is HCA HealthONE Sky Ridge in Lone Tree, Colorado, part of HCA Healthcare. Dr. Shabason is also affiliated with HCA HealthONE Swedish. The medical group on file is Rocky Mountain Cancer Centers. Dmand AI also links Dr. Shabason to 1 more ambulatory surgery center, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shabason practices, 3 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Shabason's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Shabason is licensed in Colorado.

CMS data shows 1,128 Medicare services from Dr. Shabason across 13 procedure codes in 2024, for 113 Medicare patients. Medicare paid $81,667 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 113 Medicare patients who saw Dr. Shabason in 2024. The largest group is 65 to 74, with 54 patients. 75% of them have cancer, and 75% have high cholesterol. Their average risk score is 1.45, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Shabason's median patient age at 71, with 71% women.

In 2024, Dr. Shabason wrote 20 Medicare Part D claims for 16 patients. 95% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $242 in total drug cost. In 2019, CMS named 20 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Shabason for performance year 2024, reported as part of a group. Dr. Shabason accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Shabason as offering telehealth.

Dmand AI links 34 papers to Dr. Shabason, published from 2013 to 2023. 2018 was the busiest year, with 8. The most frequent topics are Sarcoma, Breast Neoplasms and Immunotherapy. Dr. Shabason has published most often in Int J Radiat Oncol Biol Phys. Dr. Shabason's most frequent co-authors are Sriram Venigalla, MD, David Marshall Guttmann, MD and John N. Lukens, MD.

CMS Open Payments shows 16 general payments to Dr. Shabason from 8 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 78% of the total. Monteris Medical Corporation paid the most, $383.

Dr. Shabason graduated from Perelman School of Med at the University of Pennsylvania in 2011.